USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Innovative Cellular Therapeutics Holdings, Ltd.

USPTO PatentsView assignee record - 47 granted patents across 5 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

RSS updates for this company

The verdict

According to USPTO PatentsView, Innovative ranks #7,022 of 49,997 tracked US assignees by granted-patent volume, with 47 patents across 5 technology areas.

#7,022
of 49,997 US assignees by volume
Top 20%
by Innovation Score (46.8/100)
15.7
avg claims per patent
+900%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7022 · Foreign Corporation #7,022 · 47 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 47 grants
  • UPPER-Q #7,022/49,997
  • PHOTO-FINISH ImmunityBio
  • CPC-NARROW C07K · 5 areas
  • INNOV-PAR 46.8/100
  • CLAIMS-RICH 15.7 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +900% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: ImmunityBio, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Innovative’s 46.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Innovative

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Innovative's Innovation Score is 46.8/100 (top 20% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Innovative?

Each dot is one of Innovative’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Innovative’s own 15.7 claims/patent is at or below the 16.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Innovative vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 46.947.047.04747.047.047.1 051015202530 Granted patents (volume) Avg claims / patent Inside Secure - 47, 18.36Inside SecureIntelligent Designs 2000 Corp. - 47, 3.96Intelligent Desig…Iteris, Inc. - 47, 25.06IterisImmunityBio, Inc. - 47, 17.34ImmunitybioJMS Co., Ltd. - 47, 10.72JMSKennedy Valve Company - 47, 16.11Kennedy ValveKirchhoff Automotive Deutschland GmbH - 47, 15.49Kirchhoff Automot…Kreg Enterprises, Inc. - 47, 22.89Kreg EnterprisesInnovative Cellular Therapeutics Holdings, Ltd. - 47, 15.72Innovative Cellul…
Innovative vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Innovative's grants concentrate

Innovative Cellular Therapeutics Holdings, Ltd. is a focused PatentsView assignee: 5 CPC subclasses with 97.9% of grants classified under C07K (Peptides). Peak complete grant year is 2024 (16 grants) versus a trough of 1 in 2018. By volume, Innovative sits between Inside Secure and Kreg Enterprises, Inc..

Innovative's three-year grant acceleration

Innovative Cellular Therapeutics Holdings, Ltd. shows 29 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Innovative's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Innovative holds 47 patents at rank #7,025, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Innovative

By rank, the assignees closest to #7,025 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Innovative's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Innovative, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), Innovative ranks #202 of 3,615 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (47 here).

Innovative's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 20% higher than 80% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 201720182019202020212022202320242025 3
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Innovative Cellular Therapeutics Holdings, Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 2 4.3%
2018 1 2.1%
2019 1 2.1%
2020 6 12.8%
2021 5 10.6%
2022 2 4.3%
2023 11 23.4%
2024 16 34.0%
2025partial year 3 6.4%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Innovative Cellular Therapeutics Holdings, Ltd.'s patent record in context - here's where to go next.

  • Innovative Cellular Therapeutics Holdings, Ltd.'s lead technology class is C07K (Peptides), 97.9% of its portfolio - see every assignee active in that class. Explore C07K
  • Ranked #7,022 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Innovative Cellular Therapeutics Holdings, Ltd. against Inside Secure, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 46.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.